LRA by ELISA/ACT
ELISA/ACT Biotechnologies (EAB) is the exclusive provider of the lymphocyte response assay (LRA by ELISA/ACT®) tests – the gold standard in delayed hypersensitivity testing.
Built on a strong foundation of patented technology, patient-friendly guidance, value-added support, and proven results, EAB will provide you with a successful plan to determine and address the causes of chronic disease and immune system dysfunction and restore overall health.
These eight tests measure the major causes of suffering and early death. When compared to healthy goal values, results of these eight independent, primary, predictive tests are effective forecasters of individual health risk or resilience.
You can function years – or even decades – younger than your birth age just by bringing (or keeping) each of these biomarkers at their predictive (healthy) goal value.